CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...

We've been pushing the state of the art on how you do AI and machine learning on high-velocity data,' FogHorn CEO David King ... by electronics distribution giant Wesco for $4.5 billion.